UONDDL
IRWD icon

University of Notre Dame du Lac’s Ironwood Pharmaceuticals IRWD Stock Holding History

University of Notre Dame du Lac’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-221,500
Closed -$2.51M – 63
2019
Q1 		$2.51M Buy
+221,500
New +$2.47M 0.56% 55
2017
Q2 		– Sell
-171,060
Closed -$2.44M – 84
2017
Q1 		$2.44M Buy
+171,060
New +$2.34M 0.61% 62

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return

University of Notre Dame du Lac's IRWD Position: Q2 2019 in Review

University of Notre Dame du Lac sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2019, closing a stake of 221,500 shares — an estimated $2.51M sold.

University of Notre Dame du Lac first reported a position in IRWD in Q1 2017 and held it in 2 quarters. The position peaked at $2.51M in Q1 2019. 152 funds tracked by Wall St. Rank hold IRWD as of Q2 2019.

  • University of Notre Dame du Lac reported no remaining Ironwood Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • University of Notre Dame du Lac sold 221,500 Ironwood Pharmaceuticals shares in Q2 2019, an estimated $2.51M.
  • University of Notre Dame du Lac first reported a position in Ironwood Pharmaceuticals in Q1 2017 and held it in 2 quarters.
  • University of Notre Dame du Lac's Ironwood Pharmaceuticals position peaked at $2.51M in Q1 2019.
  • 152 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2019.

Based on University of Notre Dame du Lac's 13F filing for Q2 2019, filed 14 Aug 2019.